Activating transcription factor 3 coordinates differentiation of cardiac and hematopoietic progenitors by regulating glucose metabolism.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
03
08
2019
accepted:
27
01
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
9
4
2022
Statut:
epublish
Résumé
The cardiac and hematopoietic progenitors (CPs and HPs, respectively) in the mesoderm ultimately form a well-organized circulation system, but mechanisms that reconcile their development remain elusive. We found that activating transcription factor 3 (
Identifiants
pubmed: 32494702
doi: 10.1126/sciadv.aay9466
pii: aay9466
pmc: PMC7202888
doi:
Substances chimiques
Activating Transcription Factor 3
0
Cyclic AMP Response Element-Binding Protein
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eaay9466Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
J Clin Invest. 1999 Dec;104(12):1703-14
pubmed: 10606624
J Biol Chem. 2008 Jun 27;283(26):18002-11
pubmed: 18408001
Dev Cell. 2007 Aug;13(2):254-67
pubmed: 17681136
Development. 2011 Nov;138(21):4801-12
pubmed: 21989919
J Pediatr. 2018 Apr;195:275-278
pubmed: 29254757
EMBO J. 2000 Nov 1;19(21):5856-63
pubmed: 11060036
Blood. 2004 Feb 1;103(3):1020-5
pubmed: 14525774
Dev Dyn. 2006 Jan;235(1):60-7
pubmed: 16258937
Oncol Rep. 2013 Aug;30(2):553-9
pubmed: 23756559
Science. 1995 Aug 25;269(5227):1108-12
pubmed: 7652557
Mol Cell. 2003 Apr;11(4):915-26
pubmed: 12718878
Nat Commun. 2017 Mar 03;8:14640
pubmed: 28256502
Genes Dev. 1989 Dec;3(12B):2021-4
pubmed: 2697636
J Clin Invest. 2012 Dec;122(12):4490-504
pubmed: 23160200
Development. 2011 Aug;138(15):3235-45
pubmed: 21750034
Development. 2014 Aug;141(16):3112-22
pubmed: 25038045
Dev Cell. 2008 May;14(5):661-73
pubmed: 18477450
J Biol Chem. 2001 Aug 3;276(31):29507-14
pubmed: 11371557
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):814-9
pubmed: 19129488
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10032-7
pubmed: 10944195
Leukemia. 2018 Feb;32(2):479-491
pubmed: 28642593
J Exp Med. 1999 Dec 6;190(11):1573-82
pubmed: 10587348
Mol Genet Genomics. 2013 Dec;288(12):717-25
pubmed: 24036575
Mol Endocrinol. 2010 Jul;24(7):1423-33
pubmed: 20519332
Genes Dev. 1995 Jul 1;9(13):1654-66
pubmed: 7628699
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1226-31
pubmed: 18212116
Cell. 2012 Aug 3;150(3):590-605
pubmed: 22863011
J Exp Med. 2008 Sep 29;205(10):2349-57
pubmed: 18794337
Cell Stem Cell. 2014 Aug 7;15(2):169-84
pubmed: 24953180
Development. 2009 May;136(9):1465-74
pubmed: 19297410
J Clin Invest. 1999 Jan;103(2):207-13
pubmed: 9916132
Cardiovasc Res. 2017 Feb 02;113(4):399-410
pubmed: 28158532
Proc Natl Acad Sci U S A. 2015 Mar 3;112(9):2699-704
pubmed: 25730876
Am J Pathol. 2001 Aug;159(2):639-50
pubmed: 11485922
Transl Pediatr. 2015 Apr;4(2):76-92
pubmed: 26835364
PLoS One. 2017 Aug 31;12(8):e0182475
pubmed: 28859084
Circulation. 2011 Apr 19;123(15):1633-41
pubmed: 21464046
J Exp Med. 2013 Feb 11;210(2):339-53
pubmed: 23319699
Development. 2013 Oct;140(20):4203-13
pubmed: 24026123